HAPPY NEW YEAR 2022!
Always look for the shining star!
And Clear Skies as in Malta December 31, 2021!
As 2021 comes to an end, we have much for which to BE THANKFUL!
2021 PANDEMIC ‘STARS’
A colleague’s practice with 3500 patients being treated prior and during the pandemic with optimal zinc, quercetin, Vit D, Vit C, NAC, and hormones, had only 18 patients contract Covid-19 throughout the pandemic. Of that 18, one 75 yo died with co-morbidities of COPD and Alzheimers. Omicron variant has not been reported to date.
RMC’s 450 patients treated with ‘not always’ optimal zinc, quercetin, Vit D, Vit C, and hormones, had approximately 47 patients with Covid. No one who contacted and was treated by RMC with early onset Covid went to the ER or was hospitalized. No RMC patients died of Covid.
Omicron
To date, Omicron is like a breath of fresh air as the variant is not as aggressive as Alpha or Delta. So far all patients have recovered in 5-7 days reporting congestion, headache, fever, and chills as common denominators. At RMC, approximately 50% of patients are fully vaccinated and 10% of those boosted. Omicron seems to not care if you are vaccinated or not. To date, RMC is seeing more vaccinated than unvaccinated patients with Omicron. Symptoms and duration of illness are the same for all patients.
Ivermectin, a Medication About Which There is More to Learn
Ivermectin, the inventors of whom won the Nobel Prize in Physiology and Medicine in 2015, may be one of the silver linings from the Pandemic.
Anecdotally in my practice, Ivermectin use has reportedly decreased symptoms within 24 hours in patient’s positive for Covid-19. To date at RMC, there have been no side effects reported.
Anecdotally at RMC, Ivermectin has also been reported to:
- Decrease upper respiratory tract infections in patients negative for Covid in 24 hours
- Clear chronic sinusitis with long term use
- Decrease flu symptoms in 24 hours
- Normalize a 4 year chronically elevated CRP (inflammation marker)
- Improved speech, conversation, and eye contact in an Autistic Child when being treated for Covid with Ivermectin. His improvement continues a month after Covid.*
- Help fight chronic Lyme disease**
- Help treat Rosacea topically***
Other Research with Ivermectin
August 2021, research was published “suggesting Ivermectin might be a new potential anticancer drug therapy for human colorectal cancer and other cancers”.****
September 2020, a clinical review, “Ivermectin a potential anticancer drug derived from an anti-parasitic drug”, reviews Ivermectin’s “powerful antitumor effects inhibiting tumor growth and metastasis, decreasing angiogenic activity, and reversing multidrug resistance and exerting optimal effect when used in combination with other chemotherapy drugs.” It discusses Ivermectin’s effect on cancer of the breast, digestive system, renal cell carcinoma, prostate, blood leukemia,, cervical, ovarian, brain’s glioma, lung cancer, nasopharyngeal cancer, and melanoma!! Unbelievable!*****
September 2015, a study showed Ivermectin decreased alcohol consumption in mice in order to enable further clinical investigation using Ivermectin as a treatment for Alcohol Use Disorder. Also amazing!******
What an incredible gift Ivermectin is to us all for so many, many reasons!
2022 is another gift for us.
Look for SHINING STARS and CLEAR SKIES in the New Year, and see what miracles come into your life.
Have an awesome 2022!! Dr. D
*https://health.ucsd.edu/news/topics/suramin-autism/pages/default.aspx Suramin and Autism
**https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625054/Evaluation of Inhibitory effect of Ivermectin on the growth of Babesia and Theileria parasites in vitro and vivo
*** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807898/New Developments in treatment of rosacea-role of once daily ivermectin cream
****https://pubmed.ncbi.nlm.nih.gov/34483925/ Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth.
***** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/Ivermectin a potential anticancer drug derived from an antiparasitic drug
****** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554813/ Oral delivery of IVM Using a Fast Dissolving Oral Film: Implications for Repurposing IVM as a Pharmacotherapy for Alcohol Use Disorder